25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

IIQ (Inoviq) Stock Analysis
Buy, Hold or Sell?

Let's analyze Inoviq together

I guess you are interested in Inoviq Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Inoviq’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Inoviq’s Price Targets

I'm going to help you getting a better view of Inoviq Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Inoviq Ltd

I send you an email if I find something interesting about Inoviq Ltd.

1. Quick Overview

1.1. Quick analysis of Inoviq (30 sec.)










1.2. What can you expect buying and holding a share of Inoviq? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
20.0%

What is your share worth?

Current worth
A$0.12
Expected worth in 1 year
A$0.03
How sure are you?
50.0%

+ What do you gain per year?

Total Gains per Share
A$-0.09
Return On Investment
-26.9%

For what price can you sell your share?

Current Price per Share
A$0.35
Expected price per share
A$0.335 - A$0.375
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Inoviq (5 min.)




Live pricePrice per Share (EOD)
A$0.35
Intrinsic Value Per Share
A$-0.43 - A$-0.05
Total Value Per Share
A$-0.31 - A$0.07

2.2. Growth of Inoviq (5 min.)




Is Inoviq growing?

Current yearPrevious yearGrowGrow %
How rich?$10.8m$12.9m-$2.1m-19.6%

How much money is Inoviq making?

Current yearPrevious yearGrowGrow %
Making money-$4.5m-$4.2m-$245.6k-5.5%
Net Profit Margin-381.9%-1,224.8%--

How much money comes from the company's main activities?

2.3. Financial Health of Inoviq (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#94 / 126

Most Revenue
#110 / 126

Most Profit
#82 / 126

Most Efficient
#114 / 126
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Inoviq?

Welcome investor! Inoviq's management wants to use your money to grow the business. In return you get a share of Inoviq.

First you should know what it really means to hold a share of Inoviq. And how you can make/lose money.

Speculation

The Price per Share of Inoviq is A$0.35. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inoviq.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inoviq, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.12. Based on the TTM, the Book Value Change Per Share is A$-0.02 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inoviq.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.03-9.3%-0.03-9.3%-0.03-8.8%-0.04-10.0%-0.05-13.9%-0.03-8.6%
Usd Book Value Change Per Share-0.02-4.4%-0.02-4.4%0.000.5%-0.02-5.2%0.012.7%0.012.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.1%0.000.1%
Usd Total Gains Per Share-0.02-4.4%-0.02-4.4%0.000.5%-0.02-5.2%0.012.8%0.012.1%
Usd Price Per Share0.24-0.24-0.36-0.39-0.53-0.27-
Price to Earnings Ratio-7.41--7.41--11.86--10.81--11.76--6.48-
Price-to-Total Gains Ratio-15.69--15.69-209.51-60.07-16.64-8.17-
Price to Book Ratio3.07-3.07-3.89-4.32-4.77-3.32-
Price-to-Total Gains Ratio-15.69--15.69-209.51-60.07-16.64-8.17-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.227325
Number of shares4398
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.01
Usd Total Gains Per Share-0.020.01
Gains per Quarter (4398 shares)-67.3543.25
Gains per Year (4398 shares)-269.39172.98
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-269-2794169163
20-539-5489337336
30-808-81713506509
40-1078-108617674682
50-1347-135522843855
60-1616-16242610121028
70-1886-18933111801201
80-2155-21623513491374
90-2425-24313915171547
100-2694-27004416861720

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%8.025.00.024.2%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%19.014.00.057.6%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%2.00.08.020.0%3.00.030.09.1%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%19.014.00.057.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Inoviq Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.024-0.0240%0.003-982%-0.028+18%0.015-260%0.011-319%
Book Value Per Share--0.1200.1200%0.144-16%0.135-11%0.164-26%0.095+27%
Current Ratio--5.7525.7520%7.074-19%6.340-9%6.524-12%7.080-19%
Debt To Asset Ratio--0.0940.0940%0.079+19%0.087+8%0.095-1%0.167-43%
Debt To Equity Ratio--0.1040.1040%0.086+21%0.096+9%0.106-1%0.300-65%
Dividend Per Share----0%-0%-0%0.000-100%0.001-100%
Enterprise Value--56125132.46056125132.4600%85228185.480-34%88410572.413-37%118738855.980-53%62532754.402-10%
Eps---0.050-0.0500%-0.047-5%-0.054+8%-0.075+49%-0.046-7%
Ev To Ebitda Ratio---9.115-9.1150%-12.849+41%-11.751+29%-16.384+80%-9.455+4%
Ev To Sales Ratio--30.91830.9180%159.270-81%167.096-81%189.838-84%267.554-88%
Free Cash Flow Per Share---0.034-0.0340%-0.032-6%-0.040+16%-0.042+22%-0.027-21%
Free Cash Flow To Equity Per Share---0.020-0.0200%0.010-291%-0.021+9%-0.006-69%0.002-1327%
Gross Profit Margin--1.0681.0680%1.066+0%1.073-1%1.050+2%1.026+4%
Intrinsic Value_10Y_max---0.048----------
Intrinsic Value_10Y_min---0.432----------
Intrinsic Value_1Y_max---0.022----------
Intrinsic Value_1Y_min---0.043----------
Intrinsic Value_3Y_max---0.054----------
Intrinsic Value_3Y_min---0.130----------
Intrinsic Value_5Y_max---0.069----------
Intrinsic Value_5Y_min---0.217----------
Market Cap48571480.300-6%51346993.46051346993.4600%77714368.480-34%82340223.747-38%112408282.980-54%57619653.202-11%
Net Profit Margin---3.819-3.8190%-12.248+221%-12.864+237%-22.623+492%-43.115+1029%
Operating Margin---4.046-4.0460%-14.645+262%-15.000+271%-25.582+532%-50.763+1155%
Operating Ratio--6.8386.8380%15.645-56%17.764-62%19.251-64%58.158-88%
Pb Ratio2.906-6%3.0723.0720%3.888-21%4.325-29%4.773-36%3.318-7%
Pe Ratio-7.007+5%-7.407-7.4070%-11.857+60%-10.805+46%-11.757+59%-6.482-12%
Price Per Share0.350-6%0.3700.3700%0.560-34%0.593-38%0.810-54%0.415-11%
Price To Free Cash Flow Ratio-10.190+5%-10.772-10.7720%-17.280+60%-14.725+37%-19.137+78%-14.038+30%
Price To Total Gains Ratio-14.845+5%-15.693-15.6930%209.512-107%60.075-126%16.639-194%8.167-292%
Quick Ratio--4.4194.4190%6.846-35%5.733-23%6.059-27%6.851-36%
Return On Assets---0.376-0.3760%-0.302-20%-0.365-3%-0.404+7%-0.851+127%
Return On Equity---0.415-0.4150%-0.328-21%-0.400-4%-0.445+7%-1.583+282%
Total Gains Per Share---0.024-0.0240%0.003-982%-0.028+18%0.015-256%0.011-307%
Usd Book Value--10856024.88310856024.8830%12981120.036-16%12192448.424-11%14765177.807-26%8540786.267+27%
Usd Book Value Change Per Share---0.015-0.0150%0.002-982%-0.018+18%0.010-260%0.007-319%
Usd Book Value Per Share--0.0780.0780%0.094-16%0.088-11%0.106-26%0.062+27%
Usd Dividend Per Share----0%-0%-0%0.000-100%0.000-100%
Usd Enterprise Value--36453273.53336453273.5330%55355706.469-34%57422666.782-37%77120886.959-53%40615023.984-10%
Usd Eps---0.032-0.0320%-0.031-5%-0.035+8%-0.048+49%-0.030-7%
Usd Free Cash Flow---3095953.464-3095953.4640%-2920971.020-6%-3589737.571+16%-3780095.846+22%-2444005.953-21%
Usd Free Cash Flow Per Share---0.022-0.0220%-0.021-6%-0.026+16%-0.027+22%-0.018-21%
Usd Free Cash Flow To Equity Per Share---0.013-0.0130%0.007-291%-0.014+9%-0.004-69%0.001-1327%
Usd Market Cap31547176.455-6%33349872.25233349872.2520%50475482.328-34%53479975.323-38%73009179.796-54%37423964.754-11%
Usd Price Per Share0.227-6%0.2400.2400%0.364-34%0.385-38%0.526-54%0.270-11%
Usd Profit---4502515.860-4502515.8600%-4256823.000-5%-4861568.120+8%-6729116.172+49%-4187019.741-7%
Usd Revenue--1179045.7941179045.7940%347559.141+239%595077.096+98%558098.333+111%292920.278+303%
Usd Total Gains Per Share---0.015-0.0150%0.002-982%-0.018+18%0.010-256%0.007-307%
 EOD+3 -5MRQTTM+0 -0YOY+8 -303Y+19 -195Y+18 -2210Y+16 -24

3.3 Fundamental Score

Let's check the fundamental score of Inoviq Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.007
Price to Book Ratio (EOD)Between0-12.906
Net Profit Margin (MRQ)Greater than0-3.819
Operating Margin (MRQ)Greater than0-4.046
Quick Ratio (MRQ)Greater than14.419
Current Ratio (MRQ)Greater than15.752
Debt to Asset Ratio (MRQ)Less than10.094
Debt to Equity Ratio (MRQ)Less than10.104
Return on Equity (MRQ)Greater than0.15-0.415
Return on Assets (MRQ)Greater than0.05-0.376
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Inoviq Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.573
Ma 20Greater thanMa 500.360
Ma 50Greater thanMa 1000.384
Ma 100Greater thanMa 2000.386
OpenGreater thanClose0.350
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Inoviq Ltd

INOVIQ Ltd develops and commercializes diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. It offers hTERT ICC test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET, an EV isolation tool for biomarker discovery and diagnostic development. It offers non-invasive, diagnostics using its proprietary exosome develops technologies for improved screening, diagnosis, treatment selection and monitoring of cancer and other diseases. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was founded in 2016 and is headquartered in Notting Hill, Australia.

Fundamental data was last updated by Penke on 2025-10-25 10:27:07.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Inoviq earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Inoviq to theΒ Diagnostics & Research industry mean.
  • A Net Profit Margin of -381.9%Β means thatΒ $-3.82 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Inoviq Ltd:

  • The MRQ is -381.9%. The company is making a huge loss. -2
  • The TTM is -381.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-381.9%TTM-381.9%0.0%
TTM-381.9%YOY-1,224.8%+842.9%
TTM-381.9%5Y-2,262.3%+1,880.4%
5Y-2,262.3%10Y-4,311.5%+2,049.2%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-381.9%1.3%-383.2%
TTM-381.9%-2.6%-379.3%
YOY-1,224.8%-2.6%-1,222.2%
3Y-1,286.4%-3.0%-1,283.4%
5Y-2,262.3%-0.4%-2,261.9%
10Y-4,311.5%0.4%-4,311.9%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Inoviq is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Inoviq to theΒ Diagnostics & Research industry mean.
  • -37.6% Return on Assets means thatΒ Inoviq generatedΒ $-0.38 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Inoviq Ltd:

  • The MRQ is -37.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -37.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-37.6%TTM-37.6%0.0%
TTM-37.6%YOY-30.2%-7.4%
TTM-37.6%5Y-40.4%+2.8%
5Y-40.4%10Y-85.1%+44.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-37.6%-0.2%-37.4%
TTM-37.6%-0.6%-37.0%
YOY-30.2%-0.3%-29.9%
3Y-36.5%-0.5%-36.0%
5Y-40.4%0.6%-41.0%
10Y-85.1%0.6%-85.7%
4.3.1.3. Return on Equity

Shows how efficient Inoviq is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Inoviq to theΒ Diagnostics & Research industry mean.
  • -41.5% Return on Equity means Inoviq generated $-0.41Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Inoviq Ltd:

  • The MRQ is -41.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -41.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.5%TTM-41.5%0.0%
TTM-41.5%YOY-32.8%-8.7%
TTM-41.5%5Y-44.5%+3.1%
5Y-44.5%10Y-158.3%+113.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.5%0.2%-41.7%
TTM-41.5%-0.7%-40.8%
YOY-32.8%-0.2%-32.6%
3Y-40.0%-0.7%-39.3%
5Y-44.5%1.1%-45.6%
10Y-158.3%0.1%-158.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Inoviq Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Inoviq is operatingΒ .

  • Measures how much profit Inoviq makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Inoviq to theΒ Diagnostics & Research industry mean.
  • An Operating Margin of -404.6%Β means the company generated $-4.05 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Inoviq Ltd:

  • The MRQ is -404.6%. The company is operating very inefficient. -2
  • The TTM is -404.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-404.6%TTM-404.6%0.0%
TTM-404.6%YOY-1,464.5%+1,060.0%
TTM-404.6%5Y-2,558.2%+2,153.7%
5Y-2,558.2%10Y-5,076.3%+2,518.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-404.6%-4.3%-400.3%
TTM-404.6%-8.9%-395.7%
YOY-1,464.5%-6.7%-1,457.8%
3Y-1,500.0%1.1%-1,501.1%
5Y-2,558.2%4.3%-2,562.5%
10Y-5,076.3%4.7%-5,081.0%
4.3.2.2. Operating Ratio

Measures how efficient Inoviq is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • An Operation Ratio of 6.84 means that the operating costs are $6.84 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Inoviq Ltd:

  • The MRQ is 6.838. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.838. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ6.838TTM6.8380.000
TTM6.838YOY15.645-8.807
TTM6.8385Y19.251-12.413
5Y19.25110Y58.158-38.907
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.8381.173+5.665
TTM6.8381.232+5.606
YOY15.6451.186+14.459
3Y17.7641.233+16.531
5Y19.2511.192+18.059
10Y58.1581.137+57.021
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Inoviq Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Inoviq is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Diagnostics & Research industry mean).
  • A Current Ratio of 5.75Β means the company has $5.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Inoviq Ltd:

  • The MRQ is 5.752. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.752. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.752TTM5.7520.000
TTM5.752YOY7.074-1.322
TTM5.7525Y6.524-0.772
5Y6.52410Y7.080-0.557
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.7522.076+3.676
TTM5.7522.278+3.474
YOY7.0742.306+4.768
3Y6.3402.401+3.939
5Y6.5242.691+3.833
10Y7.0803.146+3.934
4.4.3.2. Quick Ratio

Measures if Inoviq is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Inoviq to theΒ Diagnostics & Research industry mean.
  • A Quick Ratio of 4.42Β means the company can pay off $4.42 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Inoviq Ltd:

  • The MRQ is 4.419. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.419. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ4.419TTM4.4190.000
TTM4.419YOY6.846-2.427
TTM4.4195Y6.059-1.640
5Y6.05910Y6.851-0.792
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ4.4191.178+3.241
TTM4.4191.232+3.187
YOY6.8461.489+5.357
3Y5.7331.626+4.107
5Y6.0591.956+4.103
10Y6.8512.260+4.591
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Inoviq Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of InoviqΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Inoviq to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.09Β means that Inoviq assets areΒ financed with 9.4% credit (debt) and the remaining percentage (100% - 9.4%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Inoviq Ltd:

  • The MRQ is 0.094. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.094. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.094TTM0.0940.000
TTM0.094YOY0.079+0.015
TTM0.0945Y0.095-0.001
5Y0.09510Y0.167-0.072
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0940.398-0.304
TTM0.0940.390-0.296
YOY0.0790.406-0.327
3Y0.0870.410-0.323
5Y0.0950.411-0.316
10Y0.1670.442-0.275
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Inoviq is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Inoviq to theΒ Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 10.4% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Inoviq Ltd:

  • The MRQ is 0.104. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.104. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.104TTM0.1040.000
TTM0.104YOY0.086+0.018
TTM0.1045Y0.106-0.001
5Y0.10610Y0.300-0.194
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1040.594-0.490
TTM0.1040.595-0.491
YOY0.0860.615-0.529
3Y0.0960.612-0.516
5Y0.1060.632-0.526
10Y0.3000.681-0.381
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Inoviq generates.

  • Above 15 is considered overpriced butΒ always compareΒ Inoviq to theΒ Diagnostics & Research industry mean.
  • A PE ratio of -7.41 means the investor is paying $-7.41Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Inoviq Ltd:

  • The EOD is -7.007. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.407. Based on the earnings, the company is expensive. -2
  • The TTM is -7.407. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.007MRQ-7.407+0.400
MRQ-7.407TTM-7.4070.000
TTM-7.407YOY-11.857+4.450
TTM-7.4075Y-11.757+4.350
5Y-11.75710Y-6.482-5.276
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-7.007-0.282-6.725
MRQ-7.407-0.230-7.177
TTM-7.407-0.398-7.009
YOY-11.857-0.260-11.597
3Y-10.8051.580-12.385
5Y-11.7579.351-21.108
10Y-6.4828.149-14.631
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Inoviq Ltd:

  • The EOD is -10.190. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.772. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.772. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.190MRQ-10.772+0.582
MRQ-10.772TTM-10.7720.000
TTM-10.772YOY-17.280+6.508
TTM-10.7725Y-19.137+8.365
5Y-19.13710Y-14.038-5.099
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-10.1902.438-12.628
MRQ-10.7722.216-12.988
TTM-10.7720.683-11.455
YOY-17.280-0.677-16.603
3Y-14.725-0.308-14.417
5Y-19.137-0.303-18.834
10Y-14.038-0.579-13.459
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Inoviq is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.07 means the investor is paying $3.07Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Inoviq Ltd:

  • The EOD is 2.906. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.072. Based on the equity, the company is fair priced.
  • The TTM is 3.072. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.906MRQ3.072-0.166
MRQ3.072TTM3.0720.000
TTM3.072YOY3.888-0.816
TTM3.0725Y4.773-1.701
5Y4.77310Y3.318+1.455
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD2.9062.175+0.731
MRQ3.0721.984+1.088
TTM3.0722.107+0.965
YOY3.8882.216+1.672
3Y4.3252.470+1.855
5Y4.7733.256+1.517
10Y3.3184.136-0.818
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. All numbers in thousands.

Summary
Total Assets18,457
Total Liabilities1,743
Total Stockholder Equity16,714
 As reported
Total Liabilities 1,743
Total Stockholder Equity+ 16,714
Total Assets = 18,457

Assets

Total Assets18,457
Total Current Assets8,702
Long-term Assets9,755
Total Current Assets
Cash And Cash Equivalents 6,521
Net Receivables 164
Inventory 47
Other Current Assets 1,970
Total Current Assets  (as reported)8,702
Total Current Assets  (calculated)8,702
+/-0
Long-term Assets
Property Plant Equipment 1,076
Intangible Assets 8,679
Long-term Assets  (as reported)9,755
Long-term Assets  (calculated)9,755
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities1,513
Long-term Liabilities230
Total Stockholder Equity16,714
Total Current Liabilities
Short-term Debt 200
Accounts payable 346
Other Current Liabilities 966
Total Current Liabilities  (as reported)1,513
Total Current Liabilities  (calculated)1,513
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)230
Long-term Liabilities  (calculated)0
+/- 230
Total Stockholder Equity
Common Stock78,049
Retained Earnings -62,999
Accumulated Other Comprehensive Income 1,664
Total Stockholder Equity (as reported)16,714
Total Stockholder Equity (calculated)16,714
+/- 0
Other
Cash and Short Term Investments 6,521
Common Stock Shares Outstanding 111,213
Liabilities and Stockholders Equity 18,457
Net Debt -6,145
Net Working Capital 7,189
Short Long Term Debt Total 376



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2025-06-302024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-302005-06-302004-06-302003-06-302002-06-301999-06-301998-06-301997-06-301996-06-301995-06-301994-06-301993-06-301992-06-301991-06-301990-06-301989-06-30
> Total Assets 
1,003
622
179
368
2,340
10,501
10,514
11,437
11,326
11,565
9,466
2,872
2,663
3,504
17,439
12,597
2,785
6,133
19,964
19,595
26,848
16,292
4,226
2,824
1,848
3,293
727
1,453
7,627
7,374
33,522
30,779
21,509
21,706
18,457
18,45721,70621,50930,77933,5227,3747,6271,4537273,2931,8482,8244,22616,29226,84819,59519,9646,1332,78512,59717,4393,5042,6632,8729,46611,56511,32611,43710,51410,5012,3403681796221,003
   > Total Current Assets 
37
50
3
68
419
7,499
6,647
4,788
2,306
1,612
926
1,430
1,236
858
3,224
366
2,777
2,487
15,775
7,335
1,800
991
255
59
1,735
3,200
699
1,453
7,627
7,374
5,649
17,467
9,403
10,857
8,702
8,70210,8579,40317,4675,6497,3747,6271,4536993,2001,735592559911,8007,33515,7752,4872,7773663,2248581,2361,4309261,6122,3064,7886,6477,4994196835037
       Cash And Cash Equivalents 
37
-41
3
66
71
6,796
6,023
3,765
2,143
979
126
669
1,040
359
2,853
128
512
1,631
15,284
1,598
961
565
75
30
1,729
3,098
650
1,446
7,557
7,327
4,999
15,395
7,813
9,233
6,521
6,5219,2337,81315,3954,9997,3277,5571,4466503,0981,72930755659611,59815,2841,6315121282,8533591,0406691269792,1433,7656,0236,79671663-4137
       Short-term Investments 
0
0
0
0
346
641
591
689
153
10
22
632
119
6
3
0
0
727
478
359
812
172
132
4
4
26
17
0
0
0
0
0
0
0
0
00000000172644132172812359478727003611963222101536895916413460000
       Net Receivables 
0
50
0
2
2
62
33
334
10
488
334
128
75
265
238
64
9
100
11
5,369
11
20
22
25
2
76
32
3
61
21
220
1,706
1,193
1,274
164
1641,2741,1931,7062202161332762252220115,3691110096423826575128334488103343362220500
       Other Current Assets 
0
0
0
0
0
0
0
0
0
136
445
632
1
228
130
173
2,255
29
3
8
15
235
27
8
3
76
49
4
9
26
383
353
380
332
1,970
1,9703323803533832694497638272351583292,2551731302281632445136000000000
   > Long-term Assets 
966
572
176
300
1,921
3,002
3,867
6,650
9,020
9,953
8,540
1,442
1,428
2,646
14,216
12,231
8
3,646
4,189
12,261
25,048
15,301
3,971
2,766
113
93
28
0
0
37,177
27,873
13,313
12,105
10,848
9,755
9,75510,84812,10513,31327,87337,1770028931132,7663,97115,30125,04812,2614,1893,646812,23114,2162,6461,4281,4428,5409,9539,0206,6503,8673,0021,921300176572966
       Property Plant Equipment 
966
572
176
300
1,921
2,882
3,726
2,920
11
89
66
1,432
1,419
1,245
9,605
12,231
8
14
12
7
3
5
3
1
26
8
0
0
0
0
1,727
1,647
1,454
1,146
1,076
1,0761,1461,4541,6471,7270000826135371214812,2319,6051,2451,4191,4326689112,9203,7262,8821,921300176572966
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
11,031
11,031
11,031
11,031
0
0
0011,03111,03111,03111,03100000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
26,146
15,115
12,316
10,652
9,702
8,679
8,6799,70210,65212,31615,11526,14600000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-37,177
0
0
0
0
0
00000-37,17700000000000000000000000000000
> Total Liabilities 
182
371
202
82
729
776
619
1,129
882
731
373
544
180
723
557
1,554
741
466
937
706
246
1,187
1,309
1,936
90
459
469
323
492
899
4,465
2,487
1,893
1,719
1,743
1,7431,7191,8932,4874,465899492323469459901,9361,3091,1872467069374667411,5545577231805443737318821,12961977672982202371182
   > Total Current Liabilities 
131
345
178
82
166
210
56
67
320
169
220
356
109
723
557
1,554
741
466
937
706
246
1,187
1,309
1,936
90
459
469
301
463
876
1,459
1,796
1,518
1,535
1,513
1,5131,5351,5181,7961,459876463301469459901,9361,3091,1872467069374667411,554557723109356220169320675621016682178345131
       Short-term Debt 
87
111
137
1
15
6
3
0
0
0
5
0
0
0
0
706
490
0
0
0
0
1,000
1,156
1,821
0
69
0
0
0
0
693
357
362
614
200
20061436235769300006901,8211,1561,0000000490706000050003615113711187
       Accounts payable 
34
55
37
72
131
81
43
39
74
154
203
150
67
657
454
718
87
419
266
3
0
0
0
317
2
369
423
238
428
799
605
1,020
467
626
346
3466264671,0206057994282384233692317000326641987718454657671502031547439438113172375534
       Other Current Liabilities 
10
179
4
9
20
123
10
27
246
15
12
206
43
65
103
130
164
48
671
702
246
187
153
115
88
20
46
62
35
77
161
419
689
294
966
96629468941916177356246208811515318724670267148164130103654320612152462710123209417910
   > Long-term Liabilities 
51
26
24
0
563
566
563
1,063
563
563
153
188
70
0
0
0
0
0
0
0
0
0
0
0
0
0
0
22
29
23
3,006
691
376
185
230
2301853766913,00623292200000000000000701881535635631,0635635665630242651
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
918
642
368
162
0
0162368642918000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
23
2,088
49
7
0
0
007492,0882300000000000000000000000000000
> Total Stockholder Equity
821
251
-23
286
1,611
9,725
9,895
10,308
10,444
10,834
9,093
2,311
2,477
2,770
16,872
11,043
2,044
5,667
19,027
18,890
26,602
15,106
2,917
888
1,758
2,834
258
1,130
7,135
6,475
29,057
28,293
19,615
19,986
16,714
16,71419,98619,61528,29329,0576,4757,1351,1302582,8341,7588882,91715,10626,60218,89019,0275,6672,04411,04316,8722,7702,4772,3119,09310,83410,44410,3089,8959,7251,611286-23251821
   Common Stock
8,604
860
1,030
1,904
3,104
7,625
7,626
8,026
8,502
9,552
13,677
16,054
17,562
18,986
36,214
39,367
41,346
41,346
50,552
50,552
60,040
60,040
60,040
60,040
61,538
6,620
6,645
9,298
16,980
19,287
51,832
69,053
69,053
75,126
78,049
78,04975,12669,05369,05351,83219,28716,9809,2986,6456,62061,53860,04060,04060,04060,04050,55250,55241,34641,34639,36736,21418,98617,56216,05413,6779,5528,5028,0267,6267,6253,1041,9041,0308608,604
   Retained Earnings -62,999-56,916-51,073-30,176-23,955-12,828-9,575-7,824-6,040-3,436-59,826-56,842-56,083-45,568-35,120-33,561-31,955-35,719-40,892-29,805-19,342-16,216-15,085-13,743-3,997-2,410-1,750-1,886-1,899-2,068-1,623-1,648-1,053-609-7,841
   Accumulated Other Comprehensive Income 
58
0
0
30
130
4,168
4,168
4,168
4,168
4,168
-586
0
0
0
0
1,482
1,590
41
430
1,899
1,683
634
-1,039
-2,309
46
-351
-348
-344
-271
16
1,179
1,097
1,635
1,776
1,664
1,6641,7761,6351,0971,17916-271-344-348-35146-2,309-1,0396341,6831,899430411,5901,4820000-5864,1684,1684,1684,1684,168130300058
   Capital Surplus 00000000000000000000000000000000000
   Treasury Stock00000000000000000000000000000000000



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

All numbers in thousands.




6.5. Income Statements

All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2025-06-30. All numbers in thousands.

Gross Profit (+$)
totalRevenue1,815
Cost of Revenue-3,375
Gross Profit-1,560-1,560
 
Operating Income (+$)
Gross Profit-1,560
Operating Expense-9,039
Operating Income-10,599-10,599
 
Operating Expense (+$)
Research Development3,255
Selling General Administrative5,313
Selling And Marketing Expenses471
Operating Expense9,0399,039
 
Net Interest Income (+$)
Interest Income0
Interest Expense-22
Other Finance Cost-22
Net Interest Income0
 
Pretax Income (+$)
Operating Income-10,599
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-6,932-14,265
EBIT - interestExpense = -7,366
-6,932
-6,911
Interest Expense22
Earnings Before Interest and Taxes (EBIT)-7,344-6,911
Earnings Before Interest and Taxes (EBITDA)-6,157
 
After tax Income (+$)
Income Before Tax-6,932
Tax Provision-0
Net Income From Continuing Ops0-6,932
Net Income-6,932
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses12,414
Total Other Income/Expenses Net3,6660
 

Technical Analysis of Inoviq
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inoviq. The general trend of Inoviq is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inoviq's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Inoviq Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Inoviq Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.36 < 0.365 < 0.375.

The bearish price targets are: 0.335 > 0.335.

Know someone who trades $IIQ? Share this with them.πŸ‘‡

Inoviq Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Inoviq Ltd. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Inoviq Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Inoviq Ltd. The current macd is -0.01108039.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Inoviq price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Inoviq. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Inoviq price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Inoviq Ltd Daily Moving Average Convergence/Divergence (MACD) ChartInoviq Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Inoviq Ltd. The current adx is 22.17.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Inoviq shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Inoviq Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Inoviq Ltd. The current sar is 0.36.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Inoviq Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Inoviq Ltd. The current rsi is 40.57. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Inoviq Ltd Daily Relative Strength Index (RSI) ChartInoviq Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Inoviq Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Inoviq price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Inoviq Ltd Daily Stochastic Oscillator ChartInoviq Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Inoviq Ltd. The current cci is -43.17958783.

Inoviq Ltd Daily Commodity Channel Index (CCI) ChartInoviq Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Inoviq Ltd. The current cmo is -16.77899697.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Inoviq Ltd Daily Chande Momentum Oscillator (CMO) ChartInoviq Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Inoviq Ltd. The current willr is -40.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Inoviq is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Inoviq Ltd Daily Williams %R ChartInoviq Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Inoviq Ltd.

Inoviq Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Inoviq Ltd. The current atr is 0.01277839.

Inoviq Ltd Daily Average True Range (ATR) ChartInoviq Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Inoviq Ltd. The current obv is -2,368,626.

Inoviq Ltd Daily On-Balance Volume (OBV) ChartInoviq Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Inoviq Ltd. The current mfi is 16.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Inoviq Ltd Daily Money Flow Index (MFI) ChartInoviq Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Inoviq Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-06-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-07-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-04STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-07-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-07-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-18SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-07-29WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-11STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-14BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-18ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-08-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-28CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-09-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-09-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-09-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-02STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-10-07STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-10-09STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-10STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-10-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-10-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-20STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-21MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-10-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-11-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-11-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-11-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Inoviq Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Inoviq Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.573
Ma 20Greater thanMa 500.360
Ma 50Greater thanMa 1000.384
Ma 100Greater thanMa 2000.386
OpenGreater thanClose0.350
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Inoviq with someone you think should read this too:
  • Are you bullish or bearish on Inoviq? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inoviq? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Inoviq Ltd

I send you an email if I find something interesting about Inoviq Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Inoviq Ltd.

Receive notifications about Inoviq Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.